Lantheus Holdings, Inc. ("Lantheus" or the "Company") , the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient ...

Digital transformation in pharma has accelerated faster than perhaps once anticipated, as a result of the COVID-19 pandemic. It’s a topic that is causing debate and business pressure, as we navigate ...

Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Citeline provides intelligence, data, and ...

ProMed, a leading contract manufacturer specializing in medical-grade silicone and plastic components, provides comprehensive support for medical device, pharmaceutical, and combination drug-device ...

In today’s Pharmaceutical Executive Daily, Eli Lilly and Nimbus Therapeutics announce a major licensing deal for oral obesity treatments, Hoth Therapeutics expands its intellectual property portfolio ...

This scheme has consistently delivered the best returns in its Sector - Healthcare category across 3Y, 5Y & 7Y. This scheme has amongst the Highest Assets Under Management (₹6,459.82 Crores) among its ...

The Master’s Programme in Pharmaceutical Research, Development and Safety offers the opportunity to obtain a comprehensive overview of the life cycle of drugs and their use. The degree programme ...

Explore our campus, meet lecturers and current students, and learn more about what it's like to study at Manchester. Visit our Faculty of Biology, Medicine and Health postgraduate research events page ...

Time to act on BMRN? Chart does not reflect overnight price.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...